Numerous studies have revealed that commercial money significantly influences researchers to sway clinical trial results in favour of the drug or device they are testing.
Boost for transparency as highest ever rate of healthcare professionals named on Disclosure UK The proportion of named healthcare professionals (HCPs) in transparency data published on Disclosure UK has risen for the third year in a row, according to new 2022 data released today. The annual declara.
UK pharmaceutical companies have historically relied upon consent as the lawful basis for the disclosure of healthcare professionals’ personal data relating to transfers of value..
UK doctors have nothing to fear from the introduction of a central register listing money or benefits they receive in addition to their NHS salary, say experts today ahead of a public meeting on the issue hosted by the All-Party Parliamentary Group for First Do No Harm and The BMJ.